全文获取类型
收费全文 | 20451篇 |
免费 | 1409篇 |
国内免费 | 45篇 |
专业分类
耳鼻咽喉 | 203篇 |
儿科学 | 555篇 |
妇产科学 | 452篇 |
基础医学 | 2605篇 |
口腔科学 | 321篇 |
临床医学 | 2319篇 |
内科学 | 4170篇 |
皮肤病学 | 238篇 |
神经病学 | 1882篇 |
特种医学 | 830篇 |
外国民族医学 | 27篇 |
外科学 | 3410篇 |
综合类 | 188篇 |
一般理论 | 13篇 |
预防医学 | 1649篇 |
眼科学 | 408篇 |
药学 | 1130篇 |
中国医学 | 24篇 |
肿瘤学 | 1481篇 |
出版年
2023年 | 147篇 |
2022年 | 323篇 |
2021年 | 664篇 |
2020年 | 365篇 |
2019年 | 526篇 |
2018年 | 617篇 |
2017年 | 472篇 |
2016年 | 508篇 |
2015年 | 593篇 |
2014年 | 829篇 |
2013年 | 984篇 |
2012年 | 1411篇 |
2011年 | 1515篇 |
2010年 | 808篇 |
2009年 | 635篇 |
2008年 | 1160篇 |
2007年 | 1081篇 |
2006年 | 1050篇 |
2005年 | 954篇 |
2004年 | 828篇 |
2003年 | 800篇 |
2002年 | 777篇 |
2001年 | 351篇 |
2000年 | 337篇 |
1999年 | 305篇 |
1998年 | 172篇 |
1997年 | 135篇 |
1996年 | 106篇 |
1995年 | 101篇 |
1994年 | 78篇 |
1993年 | 92篇 |
1992年 | 209篇 |
1991年 | 199篇 |
1990年 | 194篇 |
1989年 | 173篇 |
1988年 | 158篇 |
1987年 | 140篇 |
1986年 | 142篇 |
1985年 | 146篇 |
1984年 | 124篇 |
1983年 | 93篇 |
1982年 | 84篇 |
1981年 | 74篇 |
1979年 | 74篇 |
1978年 | 76篇 |
1977年 | 75篇 |
1976年 | 67篇 |
1975年 | 65篇 |
1974年 | 81篇 |
1973年 | 67篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
Catherine E. Oldenburg Till Bärnighausen Guy Harling Matthew J. Mimiaga Kenneth H. Mayer 《AIDS and behavior》2014,18(2):217-225
To characterize adherence to post-exposure prophylaxis after non-forcible sexual exposure to HIV, we conducted a review of the literature and meta-analysis. Articles were considered if they contained primary adherence data following non-forcible sexual exposure. Random-effects meta-analysis was used to create pooled point estimates for adherence. Of 1,257 abstracts identified through our search algorithm, 17 were eligible for inclusion in this review, representing 3,634 patients enrolled in 3 randomized controlled trials (RCTs), 9 prospective and 5 retrospective observational studies. Pooled adherence, primarily assessed by self-report, was 77 % [95 % confidence interval (CI) 68–87] in prospective observational studies, 81 % (95 % CI 65–96) in retrospective studies, 78 % (95 % CI 65–91) in RCTs, and 78 % (95 % CI 72–85) overall. Overall adherence was moderately high, with high variability between studies. Assessment of adherence could be enhanced by the use of objective measurements. 相似文献
993.
994.
995.
996.
Normal pregnancy and childbirth are known to be associated with marked changes in the coagulation and fibrinolytic systems. Generally, enhancement of clotting activity persists to prevent the risk of major hemorrhage. Hemostatic problems, either associated with a specific complication of pregnancy and labor or due to a hereditary or acquired bleeding diathesis or thrombophilias, present a significant cause of maternal and neonatal morbidity and mortality. This article reviews hemostatic disorders in pregnancy and the peripartal period from the standpoint of the obstetrician. 相似文献
997.
998.
Gain in strength and muscular balance after balance training. 总被引:1,自引:0,他引:1
H C Heitkamp T Horstmann F Mayer J Weller H H Dickhuth 《International journal of sports medicine》2001,22(4):285-290
The isolated effect of balance training on muscle strength of the flexors and extensors of the knee, without accompanying strength training, has not been addressed in the past. Effects of a balance training program alone were compared to a strength training program. Balance and strength training were performed by 15 persons each for 6 weeks including 12 training units of 25 min. Balance training was performed on instability training devices such as rolling board, mini trampoline and large rubber ball. The 15 persons of the strength training group trained on machines for leg curls and on leg presses for 25 min per unit. Measurements for balance were performed with one-leg balance on a narrow edge and a tilting stabilometer for 30 s; maximum isometric strength was measured using an isokinetic device for each leg separately. The muscular balance between dominant and non-dominant leg was calculated. Strength gain was similar for the flexors and extensors in both groups. One-leg balance improved after balance training (P< 0.01) with a 100% increase over the strength training group (P < 0.05) and the stabilometer test for each person in the balance (P < 0.01), but not in the strength training group. In the balance group the initial difference between right and left diminished. The results indicate balance training to be effective for gain in muscular strength, and secondly, in contrast to strength training, equalisation of muscular imbalances may be achieved after balance training. 相似文献
999.
C Bokemeyer K Oechsle F Honecker F Mayer J T Hartmann C F Waller I B?hlke C Kollmannsberger 《Annals of oncology》2008,19(3):448-453
BACKGROUND: The aim of this study is to determine feasibility and efficacy of the combination regimen gemcitabine, oxaliplatin, and paclitaxel (GOP) in patients with cisplatin-refractory or multiply relapsed germ-cell tumors. PATIENTS AND METHODS: From April 2003 to October 2006, 41 patients refractory to cisplatin-based chemotherapy or with relapse after high-dose chemotherapy (HDCT) plus stem-cell support (peripheral blood stem-cell transplantation: PBSCT) received 800 mg/m2 gemcitabine, 80 mg/m2 paclitaxel (Taxol), both on days 1 + 8, and oxaliplatin 130 mg/m2 on day 1 of a 3-week cycle for a minimum of two cycles. Primary end point was response rate. Patients were pretreated with a median of two lines of platin-based chemotherapy (range, 1-3), and 78% had relapsed after HDCT/PBSCT. RESULTS: Seventy-three percent of patients had relapsed within 3 months after the last cisplatin-based chemotherapy. Five percent of the patients achieved a complete response, and 34% and 12% a marker-negative and marker-positive partial response, respectively (overall response rate 51%). After a median follow-up of 5 months (range, 0-20), 15% of the patients remain in complete remission after GOP chemotherapy +/- residual tumor resection with a median response duration of 8 months (1 to 17+). Main toxicity was leucocytopenia grade 3/4 in 15%, anemia in 7%, and thrombocytopenia in 49% of the patients. CONCLUSION: Combination chemotherapy with GOP is feasible and effective with acceptable toxicity in patients with treatment-refractory germ-cell tumors. 相似文献
1000.
G D'Addario D Rauch R Stupp M Pless R Stahel N Mach L Jost L Widmer C Tapia M Bihl M Mayer K Ribi S Lerch L Bubendorf D C Betticher 《Annals of oncology》2008,19(4):739-745
BACKGROUND: Gefitinib is active in patients with pretreated non-small-cell lung cancer (NSCLC). We evaluated the activity and toxicity of gefitinib first-line treatment in advanced NSCLC followed by chemotherapy at disease progression. PATIENTS AND METHODS: In all, 63 patients with chemotherapy-naive stage IIIB/IV NSCLC received gefitinib 250 mg/day. At disease progression, gefitinib was replaced by cisplatin 80 mg/m(2) on day 1 and gemcitabine 1250 mg/m(2) on days 1, 8 for up to six 3-week cycles. Primary end point was the disease stabilization rate (DSR) after 12 weeks of gefitinib. RESULTS: After 12 weeks of gefitinib, the DSR was 24% and the response rate (RR) was 8%. Median time to progression (TtP) was 2.5 months and median overall survival (OS) 11.5 months. Never smokers (n = 9) had a DSR of 56% and a median OS of 20.2 months; patients with epidermal growth factor receptor (EGFR) mutation (n = 4) had a DSR of 75% and the median OS was not reached after the follow-up of 21.6 months. In all, 41 patients received chemotherapy with an overall RR of 34%, DSR of 71% and median TtP of 6.7 months. CONCLUSIONS: First-line gefitinib monotherapy led to a DSR of 24% at 12 weeks in an unselected patients population. Never smokers and patients with EGFR mutations tend to have a better outcome; hence, further trials in selected patients are warranted. 相似文献